Existing packaging lines can be retrofitted for serialization tasks, achieving a maximum of space savings and process reliability: if required, the system comes with an integrated checkweigher and tamper-evident labeler.
Come and visit Atlantic Zeiser (booth 114) at Making Pharmaceuticals in Coventry this April. We’ll be at the Ricoh Arena (April 25th – 26th 2017) to discuss all of your Serialization and Late Stage Customisation requirements.
Sobering facts from the “Serialization, Track & Trace Symposium” at Pharmapack 2017 in Paris – alternative approaches explained.
Particular insight on how the future of serialization and late-stage printing will look like.
The complete color late stage customization of pharmaceutical carton boxes helps to minimize costs.
interpack magazine on the subject of serialization.
With a revolutionary approach regarding flat cartons and labels for pharmaceutical products, Atlantic Zeiser has demonstrated excellence in this field.
The opening presentation of day two at the “drupa touchpoint”, the official forum for innovative and trendsetting packaging solutions at this year’s drupa was held by Michael Urso, Product Manager for Pharma Packaging Solutions at Atlantic Zeiser.
Pharmaceutical serialization for China: The QR code that becomes obligatory for all veterinary medicines in China from June 30, 2016 is presenting most pharmaceutical producers and flat carton manufacturers with significant printing challenges.
The serialization of drug packaging is about to become mandatory in a large number of countries. As general awareness of this challenge grows, businesses are increasingly preoccupied with the practical question of where best in the process chain to apply the codes.
This will be the title of Atlantic Zeiser’s presentation during the Interphex in New York from 26th – 28th April 2016.
Plan your timeline in advance: For a first-time serialization and aggregation pilot project, more than two years should be set aside for the desired level of success.
Amongst many another stakeholders in the global fight against counterfeit medicines, Atlantic Zeiser presented solutions for one of the key and legislative requirements outlined in the recently published delegated act (EU) 2016/161 to address this serious issue.
The directive (EU) 2016/161 “Falsified Medicines Directive“ has now been published. During the 10th Jahresforum Pharma Packaging in Berlin numerous experts discussed this topic, among them Dr. Stefan Oeing, Director Business Development at Atlantic Zeiser.